In State of New Mexico, ex rel. Hector H. Balderas, Attorney General v. Solvay Pharmaceuticals, Inc., Eric Gaier served as testifying expert regarding causation in connection with alleged off-label marketing of the testosterone replacement therapy drug AndroGel® and challenged non-branded low testosterone disease state awareness campaigns that allegedly violated New Mexico’s Unfair Practices Act and False Advertising Act. The matter settled before trial.
Partner with a firm that delivers rigorous economic research and practical advice.
By using this site, you agree to our updated Cookie Policy, Privacy Policy, and our Terms & Conditions.
When you visit our website, we use cookies on your browser to collect information. The information collected might relate to you, your preferences, or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. For more information about how we use cookies, please see our Cookie Policy and Privacy Policy.
